Business

A provider of integrated drug discovery services to the Pharmaceutical and Biotechnology sectors.

UK company dedicated to the discovery of novel drug candidates in the anti-infective area.

Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day.

Research-based biopharmaceutical company seeking to discover and develop new healthcare solutions to treat and diagnose crucial unmet medical conditions in the neurological and oncological sectors. Padua, Italy.

Early stage drug discovery opportunities, research expertise and facilities, and intellectual property available for licensing from the Strathclyde Institute for Drug Research, University of Strathclyde, Glasgow, Scotland.

A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.

Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders.

The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease.

Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards.

A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.

Provides services in pharmacology, in molecular biology and lead development, in toxicology, metabolism and bio-availability, in combinatorial chemistry, HTS, HTP, HTLD and computational chemistry.

Core business is formulation development together with clinical trial material manufacturing and commercial manufacture of low volume products.

Developing platform electroporation technology for targeted in vivo delivery of membrane limited therapeutic agents including pharmaceutical compounds and DNA-based therapies.

Compounding and research pharmacy with a focus in drug delivery systems, primarily in the topical therapeutic application of drugs. PDL has developed several new compounds for the management of pain and nausea, especially for the terminally ill hospice patient.

Originators of clinical saliva testing for female and male hormones.

Australian biomedical research company, which funds, manages, and commercialises diagnostic and therapeutic research projects including cancer diagnostic tests and antiviral agents.

Studies, publications, and news about the diagnostic drugs, synthetic human and porcine secretin.

Pharmaceutical research and development company focused on developing drugs to treat diabetes, obesity and CNS disorders.

Leading company in RNA-targeted drug discovery and development for rare/orphan diseases.

Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, Massachusetts.

Drug discovery and development company with peptide drugs to treat cancer and immune-mediated diseases.

Discovers, develops, manufactures and sells pharmaceutical and nutritional products such as drug delivery systems, antibiotics and prepared infant formulas. Includes investor an investor relations area, and a career center. (NYSE: ABT).

Develops, manufactures and markets vaccines and medications of biological origin. Includes career and investor information, and details of subsidiaries. Parkville, Victoria, Australia.

Development and distribution of products for the treatment of major diseases, with company profile and research details. Milan, Italy.

Discovery, manufacture and marketing of products used in oncology and endocrine therapy, with development strategies and investor information. Quebec, Quebec, Canada. [French and English]

Eli Lilly Ireland, specialising in women's health, depression and schizophrenia.

Development of drugs for treatment of neurovascular, respiratory and allergic disorders, with career and subsidiary information, plus international contact details.

Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX)

Supplies components for genomic studies, and provides research, development and production services for clinical manufacturing. Includes details of products and technical resources. Headquarters in Liege, Belgium.

Development and marketing of medications used in the fields of neurology, dermatology and infectious diseases. Includes corporate and production details. Headquarters in Laval, Quebec, Canada.

Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY)

Custom research organization specializing in synthesis of organic compounds, process and drug development and GMP manufacturing of pharmaceuticals and fine organic chemicals.

Jordan based pharmaceutical research center, offer services including clinical service, bioanalysis service, data management, quality assurance.

Development of techniques to focus the release of cytostatics to tumour tissue based in Uppsala, Sweden.

Biopharmaceutical research and development of treatments for migraine, obesity, sexual disfunction and Parkinson disease.

A cutting edge, privately held company devoted to providing elegant and effective solutions to long standing human healthcare issues.

Biopharmaceutical drug delivery with technology of applying its polymer coupling technology platforms and advanced analytical methods.

A specialty pharmaceutical company principally engaged in the development of oral, controlled release products.

A clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of orphan diseases.

A global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies.

Specializes in the drug discovering using GPCR targets and development focusing on oncology and anti-inflammatory drug discovery and development

California based company developing, designing, and producing a complete line of diagnostics reagents and kits for use in various health care industries.

OriGene provides its clients in the pharma-biotech and life-science communities with a complete range of genomic and proteomic discovery research services and reagents.

A company focused on the prediction and experimental evaluation of ADME and Pharmacokinetics for drug discovery.

Virinova has developed a novel virus diagnostic technology for process control and diagnostic monitoring of viral infections. No antibodies or PCR is required and the method is suitable for all virus types including unknown viruses. It allows the direct detection of virus particles in minutes.

A research based human healthcare company that discovers, develops and markets medical products in onoclogy, neurology and gastrointestinal.

A medium sized research and development company located Freiburg southwest of Germany focusing on protein kinase targeted drug discovery.

Pharmaceutical manufacturing and research company committed to providing manufacturing and scientific services to the health-care industry.

Research into Optimised Human Health through Natural Nutriture, with minimal use of dietary supplements and natural medicines, if at all. Eradication of AIDS, Parasites, Cancer, Cardiovascular Disease, and premature aging.

Canadian company providing products and services in the research and development of pharmaceuticals, including the sale of research quantities of specialty chemicals and brokering of scale-up and custom synthesis contracts.